Literature DB >> 19597705

Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.

Lyndsay V Rhodes1, Shannon E Muir, Steven Elliott, Lori M Guillot, James W Antoon, Patrice Penfornis, Syreeta L Tilghman, Virgilio A Salvo, Juan P Fonseca, Michelle R Lacey, Barbara S Beckman, John A McLachlan, Brian G Rowan, Radhika Pochampally, Matthew E Burow.   

Abstract

Adult human mesenchymal stem cells (hMSCs) have been shown to home to sites of breast cancer and integrate into the tumor stroma. We demonstrate here the effect of hMSCs on primary breast tumor growth and the progression of these tumors to hormone independence. Co-injection of bone marrow-derived hMSCs enhances primary tumor growth of the estrogen receptor-positive, hormone-dependent breast carcinoma cell line MCF-7 in the presence or absence of estrogen in SCID/beige mice. We also show hormone-independent growth of MCF-7 cells when co-injected with hMSCs. These effects were found in conjunction with increased immunohistochemical staining of the progesterone receptor in the MCF-7/hMSC tumors as compared to MCF-7 control tumors. This increase in PgR expression indicates a link between MCF-7 cells and MSCs through ER-mediated signaling. Taken together, our data reveal the relationship between tumor microenvironment and tumor growth and the progression to hormone independence. This tumor stroma-cell interaction may provide a novel target for the treatment of estrogen receptor-positive, hormone-independent, and endocrine-resistant breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597705      PMCID: PMC4943323          DOI: 10.1007/s10549-009-0458-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  27 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation.

Authors:  Shu-Hua Yang; Chang-Chin Wu; Tiffany Ting-Fang Shih; Yuan-Hui Sun; Feng-Huei Lin
Journal:  Spine (Phila Pa 1976)       Date:  2008-08-15       Impact factor: 3.468

Review 3.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

4.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

5.  Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer.

Authors:  T Hasebe; S Sasaki; M Sugitoh; M Ono; N Saitoh; A Ochiai
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

6.  Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.

Authors:  Larry N Petz; Yvonne S Ziegler; Jennifer R Schultz; Ann M Nardulli
Journal:  Mol Endocrinol       Date:  2003-12-18

7.  Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.

Authors:  Zengshan Li; Latonya Carrier; Aditi Belame; Arunthavarani Thiyagarajah; Virgilio A Salvo; Matthew E Burow; Brian G Rowan
Journal:  Breast Cancer Res Treat       Date:  2008-10-15       Impact factor: 4.872

8.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

Authors:  Matus Studeny; Frank C Marini; Richard E Champlin; Claudia Zompetta; Isaiah J Fidler; Michael Andreeff
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

Review 9.  The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles.

Authors:  B Hall; M Andreeff; F Marini
Journal:  Handb Exp Pharmacol       Date:  2007

Review 10.  Recent advances into the understanding of mesenchymal stem cell trafficking.

Authors:  James M Fox; Giselle Chamberlain; Brian A Ashton; Jim Middleton
Journal:  Br J Haematol       Date:  2007-06       Impact factor: 6.998

View more
  50 in total

Review 1.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

2.  Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

Authors:  Katja Lundgren; Nicholas P Tobin; Sophie Lehn; Olle Stål; Lisa Rydén; Karin Jirström; Göran Landberg
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

Review 3.  Mechanisms of aromatase inhibitor resistance.

Authors:  Cynthia X Ma; Tomás Reinert; Izabela Chmielewska; Matthew J Ellis
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

4.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

5.  Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

Authors:  Lyndsay V Rhodes; Syreeta L Tilghman; Stephen M Boue; Shuchun Wang; Hafez Khalili; Shannon E Muir; Melyssa R Bratton; Qiang Zhang; Guangdi Wang; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

6.  Preparation of epithelial and mesenchymal stem cells from murine mammary gland.

Authors:  Ian Guest; Zoran Ilic; Jun Ma
Journal:  Curr Protoc Toxicol       Date:  2011-11

7.  Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.

Authors:  J Huang; P Woods; D Normolle; J P Goff; P V Benos; C J Stehle; R A Steinman
Journal:  Breast Cancer Res Treat       Date:  2016-11-16       Impact factor: 4.872

8.  Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators.

Authors:  Lyndsay V Rhodes; Chandra R Tate; H Chris Segar; Hope E Burks; Theresa B Phamduy; Van Hoang; Steven Elliott; Diari Gilliam; F Nell Pounder; Muralidharan Anbalagan; Douglas B Chrisey; Brian G Rowan; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Breast Cancer Res Treat       Date:  2014-05-09       Impact factor: 4.872

9.  Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.

Authors:  Ann H Klopp; Lara Lacerda; Anshul Gupta; Bisrat G Debeb; Travis Solley; Li Li; Erika Spaeth; Wei Xu; Xiaomei Zhang; Michael T Lewis; James M Reuben; Savitri Krishnamurthy; Mauro Ferrari; Rogério Gaspar; Thomas A Buchholz; Massimo Cristofanilli; Frank Marini; Michael Andreeff; Wendy A Woodward
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

10.  Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.

Authors:  Lyndsay V Rhodes; James W Antoon; Shannon E Muir; Steven Elliott; Barbara S Beckman; Matthew E Burow
Journal:  Mol Cancer       Date:  2010-11-18       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.